Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice

The ongoing global pandemic of coronavirus disease 2019 (COVID-19) calls for an urgent development of effective and safe prophylactic and therapeutic measures. The spike (S) glycoprotein of severe acute respiratory syndrome-coronavirus (SARS-CoV-2) is a major immunogenic and protective protein and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamri, Sawsan S., Alluhaybi, Khalid A., Alhabbab, Rowa Y., Basabrain, Mohammad, Algaissi, Abdullah, Almahboub, Sarah, Alfaleh, Mohamed A., Abujamel, Turki S., Abdulaal, Wesam H., ElAssouli, M-Zaki, Alharbi, Rahaf H., Hassanain, Mazen, Hashem, Anwar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454412/
https://www.ncbi.nlm.nih.gov/pubmed/34557174
http://dx.doi.org/10.3389/fmicb.2021.727455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454412/
https://www.ncbi.nlm.nih.gov/pubmed/34557174
http://dx.doi.org/10.3389/fmicb.2021.727455

Ejemplares similares